These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17849073)

  • 21. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
    van der Klauw MM; van Rey FJ; Stricker BH
    Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new paradigm for predicting risk of Torsades de Pointes during drug development: Commentary on: "Improved prediction of drug-induced Torsades de Pointes through simulations of dynamics and machine learning algorithms".
    McCauley MD; Darbar D
    Clin Pharmacol Ther; 2016 Oct; 100(4):324-6. PubMed ID: 27301674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Zeuli JD; Wilson JW; Estes LL
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1121-7. PubMed ID: 23229485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
    Antzelevitch C
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
    Hinterseer M; Irlbeck M; Ney L; Beckmann BM; Pfeufer A; Steinbeck G; Kaab S
    Br J Anaesth; 2006 Aug; 97(2):150-3. PubMed ID: 16720674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voriconazole-induced QT interval prolongation and torsades de pointes.
    Aypar E; Kendirli T; Tutar E; Çiftçi E; Ince E; Ileri T; Atalay S
    Pediatr Int; 2011 Oct; 53(5):761-763. PubMed ID: 21955009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QT interval prolongation and torsade de pointes associated with indapamide.
    Letsas KP; Alexanian IP; Pappas LK; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2006 Oct; 112(3):373-4. PubMed ID: 16260053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V; Miljoen H; Vrints C
    Acta Cardiol; 2009 Dec; 64(6):839-42. PubMed ID: 20128168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
    Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation.
    Ösken A; Yelgeç NS; Zehir R; Öz TK; Yaylacı S; Akdemir R; Gündüz H
    Indian J Pharmacol; 2016; 48(4):462-465. PubMed ID: 27756965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.
    Jaiswal A; Goldbarg S
    Indian Heart J; 2014; 66(6):640-8. PubMed ID: 25634399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Torsades de pointes ventricular tachycardia caused by terodiline (Mictrol)?].
    Pedersen JL; Ohmsen E
    Ugeskr Laeger; 1992 Sep; 154(40):2760-1. PubMed ID: 1413214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
    Bienias P; Ciurzyński M; Paczyńska M; Pruszczyk P
    Pol Merkur Lekarski; 2014 Nov; 37(221):285-8. PubMed ID: 25546990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.